264 related articles for article (PubMed ID: 20955825)
1. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know.
Allen MR; Burr DB
Bone; 2011 Jul; 49(1):56-65. PubMed ID: 20955825
[TBL] [Abstract][Full Text] [Related]
2. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
[TBL] [Abstract][Full Text] [Related]
3. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
[TBL] [Abstract][Full Text] [Related]
4. A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage.
Nyman JS; Yeh OC; Hazelwood SJ; Martin RB
Bone; 2004 Jul; 35(1):296-305. PubMed ID: 15207770
[TBL] [Abstract][Full Text] [Related]
5. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.
Komatsubara S; Mori S; Mashiba T; Li J; Nonaka K; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
J Bone Miner Res; 2004 Jun; 19(6):999-1005. PubMed ID: 15125797
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates: how do they work?
Papapoulos SE
Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):831-47. PubMed ID: 19028359
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
[TBL] [Abstract][Full Text] [Related]
8. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
[TBL] [Abstract][Full Text] [Related]
9. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
Allen MR; Iwata K; Phipps R; Burr DB
Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
[TBL] [Abstract][Full Text] [Related]
10. [Bone Cell Biology Assessed by Microscopic Approach. The effects of bisphosphonates on bone remodeling, microdamage accumulation and fracture repair process].
Mashiba T
Clin Calcium; 2015 Oct; 25(10):1537-40. PubMed ID: 26412734
[TBL] [Abstract][Full Text] [Related]
11. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.
Chapurlat RD; Arlot M; Burt-Pichat B; Chavassieux P; Roux JP; Portero-Muzy N; Delmas PD
J Bone Miner Res; 2007 Oct; 22(10):1502-9. PubMed ID: 17824840
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in orthopedic applications.
Wilkinson JM; Little DG
Bone; 2011 Jul; 49(1):95-102. PubMed ID: 21256254
[TBL] [Abstract][Full Text] [Related]
13. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH
Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
[TBL] [Abstract][Full Text] [Related]
15. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.
Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB
Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598
[TBL] [Abstract][Full Text] [Related]
16. Microdamage in bone: implications for fracture, repair, remodeling, and adaptation.
Donahue SW; Galley SA
Crit Rev Biomed Eng; 2006; 34(3):215-71. PubMed ID: 16930125
[TBL] [Abstract][Full Text] [Related]
17. Bone microdamage and skeletal fragility in osteoporotic and stress fractures.
Burr DB; Forwood MR; Fyhrie DP; Martin RB; Schaffler MB; Turner CH
J Bone Miner Res; 1997 Jan; 12(1):6-15. PubMed ID: 9240720
[TBL] [Abstract][Full Text] [Related]
18. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair.
Sloan AV; Martin JR; Li S; Li J
Bone; 2010 Aug; 47(2):235-40. PubMed ID: 20580684
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of bone quality. Bone quality and osteoporosis treatment].
Mashiba T
Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
